Suchen
Zai Lab Ltd
ZLABZur Watchlist hinzufügen
26.440USD
+0.030+0.11%
Handelsschluss 09-23 16:00（ET）
2.97BMarktkapitalisierung
VerlustKGV TTM
Über Zai Lab Ltd Unternehmen
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
Zai Lab Ltd Profil
BörsenkürzelZLAB
Name des UnternehmensZai Lab Ltd
IPO-datumSep 28, 2020
CEODu (Ying)
Anzahl der mitarbeiter1869
WertpapierartDepository Receipt
GeschäftsjahresendeSep 28
AddresseBuilding B, 899 Halei Road, Pudong
StadtSHANGHAI
BörseNASDAQ OMX - NASDAQ BASIC
LandChina
Postleitzahl201203
Telefon862161632588
Websitehttps://www.zailaboratory.com/
BörsenkürzelZLAB
IPO-datumSep 28, 2020
CEODu (Ying)
Führungskräfte von Zai Lab Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
122.14K
+18.32%
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
122.14K
+18.32%
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
117.60K
+22.60%
Mr. Michel Pericles Vounatsos
Mr. Michel Pericles Vounatsos
Independent Director
Independent Director
72.79K
+30.73%
Mr. Michel Pericles Vounatsos
Mr. Michel Pericles Vounatsos
Independent Director
Independent Director
72.79K
+30.73%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
41.93K
-20.29%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
41.93K
-20.29%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
35.63K
-0.16%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
35.63K
-0.16%
Dr. Ying (Samantha) Du, Ph.D.
Dr. Ying (Samantha) Du, Ph.D.
Founder, Chief Executive Officer and Chairman of the Board
Founder, Chief Executive Officer and Chairman of the Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
122.14K
+18.32%
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
122.14K
+18.32%
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
117.60K
+22.60%
Mr. Michel Pericles Vounatsos
Mr. Michel Pericles Vounatsos
Independent Director
Independent Director
72.79K
+30.73%
Mr. Michel Pericles Vounatsos
Mr. Michel Pericles Vounatsos
Independent Director
Independent Director
72.79K
+30.73%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
41.93K
-20.29%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Zai Lab Ltd?
Die fünf größten Anteilseigner von Zai Lab Ltd sind: Dr. John David Diekman, Ph.D.
Was ist die größte Einnahmequelle von Zai Lab Ltd?
Am 2026Q4 erzielte das Geschäft mit ZEJULA für Zai Lab Ltd den höchsten Umsatz in Höhe von 32.08M, was 30.33% des Gesamtumsatzes entspricht.